Key result
Endovascular aortic stenting provides first reported embolic prophylaxis for a primary malignant aortic tumor.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
Endovascular aortic stenting represents a novel approach for embolic prophylaxis in patients with primary malignant tumors of the aorta.
Primary malignant tumors of the aorta (PMTAs) are an extremely rare clinical entity. In most cases, the diagnosis is made either postmortem or late in the course of disease due to a low index of clinical suspicion and presenting symptoms that mimic far more common athero-embolic processes. Due to the intravascular origin of these tumors, peripheral and mesenteric embolic events represent a major source of morbidity and mortality. We present the first reported case of a patient with a diagnosed PMTA treated with an endovascular aortic stent for the purpose of embolic prophylaxis. The presentation, diagnosis, classification, and management of PMTAs in the world literature are also reviewed.
No takes yet. Share an insight, caveat, or question.
Rusthoven et al. (2010) conducted a case report in Primary malignant tumor of the aorta (PMTA) (n=1). Endovascular aortic stent was evaluated. An endovascular aortic stent was used for embolic prophylaxis in a patient with a primary malignant tumor of the aorta, representing the first reported case of this approach.
Synapse has enriched 10 related papers. Consider them for comparative context: